Back
Johnson & Johnson Vs. Pfizer Inc. Sector Stock Comparison
Buy
62
JNJ
Johnson & Johnson
Last Price:
$207.50
Seasonality Move:
1.27%
Sell
48
PFE
Pfizer Inc.
Last Price:
$25.25
Seasonality Move:
0.42%
Buy
62
Johnson & Johnson (JNJ)
is a Buy
Is Johnson & Johnson a Buy, Sell or Hold?
-
The current Johnson & Johnson [JNJ] share price is $204.79. The Score for JNJ is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
JNJ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Pfizer Inc. (PFE)
is a Sell
Is Pfizer Inc. a Buy, Sell or Hold?
-
The current Pfizer Inc. [PFE] share price is $25.43. The Score for PFE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
PFE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $204.79The current trend is relatively stagnant and JNJ is experiencing slight selling pressure.
PFE Stock Price Chart
What is Pfizer Inc.'s stock price today?
-
The Pfizer Inc. share price today is $25.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PFE is experiencing slight selling pressure.
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.14 | Buy |
| Relative Strength Index (14 RSI): | 48.86 | Sell |
| Chaikin Money Flow: | -3881752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.48 - 209.72) | Sell |
| Bollinger Bands (100): | (179.38 - 203.28) | Buy |
PFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 53.26 | Buy |
| Chaikin Money Flow: | -20515248 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.98 - 25.76) | Buy |
| Bollinger Bands (100): | (24.31 - 25.75) | Buy |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 206.66 | Sell |
| 20-day SMA: | 207.23 | Sell |
| 50-day SMA: | 200.68 | Buy |
| 200-day SMA: | 174.55 | Buy |
| 8-day EMA: | 206.24 | Sell |
| 20-day EMA: | 206.11 | Sell |
| 50-day EMA: | 201.13 | Buy |
| 200-day EMA: | 181.04 | Buy |
PFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.1 | Buy |
| 20-day SMA: | 25.33 | Buy |
| 50-day SMA: | 25.17 | Buy |
| 200-day SMA: | 24.47 | Buy |
| 8-day EMA: | 25.18 | Buy |
| 20-day EMA: | 25.24 | Buy |
| 50-day EMA: | 25.19 | Buy |
| 200-day EMA: | 25.15 | Buy |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.88 per share.
Pfizer Inc. Earnings Growth & PFE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.11 per share.
Johnson & Johnson Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pfizer Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||